BaseSpace
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. FXYD4, Coagulation, Breast Cancer, Prostate, Avian flu virus, Valproic acid, rs2230926)
Bookmark Forward

Successful treatment of anti-PTX3 positive seronegative rheumatoid arthritis with upadacitinib.

Haojie Xu, Bang Su, Rong Li, Lu Wang, Jiaxin Zhou, Lidan Zhao

International journal of rheumatic diseases 2024 Jan


filter terms:
  • diagnosis (1)
  • humans (1)
  • patients (1)
  • rheumatoid arthritis (5)
    • Sizes of these terms reflect their relevance to your search.

    Seronegative rheumatoid arthritis (SNRA) can be a rapid-progressing and highly disabling disease. Anti-PTX3 autoantibody may be a potential biomarker in SNRA diagnosis. SNRA patients could respond well to upadacitinib. © 2023 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

    Citation

    Haojie Xu, Bang Su, Rong Li, Lu Wang, Jiaxin Zhou, Lidan Zhao. Successful treatment of anti-PTX3 positive seronegative rheumatoid arthritis with upadacitinib. International journal of rheumatic diseases. 2024 Jan;27(1):e14899

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37705400

    View Full Text
    • Copyright © 2025 Illumina Inc. All rights reserved.